A comparison of costs and hospital length of stay associated with intravenous/oral linezolid or intravenous vancomycin treatment of complicated skin and soft-tissue infections caused by suspected or confirmed methicillin-resistant Staphylococcus aureus in elderly US patientsMCCOLLUM, Marianne; SORENSEN, Sonja V; LIU, Larry Z et al.Clinical therapeutics. 2007, Vol 29, Num 3, pp 469-477, issn 0149-2918, 9 p.Article

The economics of selective serotonin reuptake inhibitors in depression: A critical reviewFRANK, Lori; REVICKI, Dennis A; SORENSEN, Sonja V et al.CNS drugs. 2001, Vol 15, Num 1, pp 59-83, issn 1172-7047Article

A Comparative Analysis of Models Used to Evaluate the Cost-Effectiveness of Dabigatran Versus Warfarin for the Prevention of Stroke in Atrial FibrillationSORENSEN, Sonja V; SIYANG PENG; MONZ, Brigitta U et al.PharmacoEconomics (Auckland). 2013, Vol 31, Num 7, pp 589-604, issn 1170-7690, 16 p.Article

Model-Based Simulation to Explore the Cost-Effectiveness of Following Practice Guidelines for Triglyceride and Low- Density Lipoprotein Cholesterol Control Among Patients With Diabetes Mellitus and Mixed DyslipidemiaSORENSEN, Sonja V; FRICK, Kevin D; WADE, Alexander et al.Clinical therapeutics. 2009, Vol 31, Num 4, pp 862-879, issn 0149-2918, 18 p.Article

Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infectionsMCKINNON, Peggy S; SORENSEN, Sonja V; LIU, Larry Z et al.The Annals of pharmacotherapy. 2006, Vol 40, Num 6, pp 1017-1023, issn 1060-0280, 7 p.Article

Atopic dermatitis is associated with a decrement in health-related quality of lifeKIEBERT, Gwendoline; SORENSEN, Sonja V; REVICKI, Dennis et al.International journal of dermatology. 2002, Vol 41, Num 3, pp 151-158, issn 0011-9059Article

Cost for inpatient care of venous thrombosis : A trial of enoxaparin vs standard heparinDE LISSOVOY, Gregory; YUSEN, Roger D; SPIRO, Theodore E et al.Archives of internal medicine (1960). 2000, Vol 160, Num 20, pp 3160-3165, issn 0003-9926Article

Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillationKANSAL, Anuraag R; SORENSEN, Sonja V; GANI, Ray et al.Heart (London 1996). 2012, Vol 98, Num 7, pp 573-578, issn 1355-6037, 6 p.Article

Cost-effectiveness of warfarin: Trial versus real-world stroke prevention in atrial fibrillationSORENSEN, Sonja V; DEWILDE, Sarah; SINGER, Daniel E et al.The American heart journal. 2009, Vol 157, Num 6, pp 1064-1073, issn 0002-8703, 10 p.Article

Comparison of the Cost-effectiveness of New Oral Anticoagulants for the Prevention of Stroke and Systemic Embolism in Atrial Fibrillation in a UK SettingZHENG, Ying; SORENSEN, Sonja V; GONSCHIOR, Ann-Katrin et al.Clinical therapeutics. 2014, Vol 36, Num 12, pp 2015-2028, issn 0149-2918, 14 p.Article

Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada: Comparative efficacy and cost-effectivenessKANSAL, Anuraag R; SHARMA, Michael; BRADLEY-KENNEDY, Carole et al.Thrombosis and haemostasis. 2012, Vol 108, Num 4, pp 672-682, issn 0340-6245, 11 p.Article

Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: A Canadian payer perspectiveSORENSEN, Sonja V; KANSAL, Anuraag R; CONNOLLY, Stuart et al.Thrombosis and haemostasis. 2011, Vol 105, Num 5, pp 908-919, issn 0340-6245, 12 p.Article

A taxonomy and economic consequences of nursing home fallsSORENSEN, Sonja V; DE LISSOVOY, Gregory; KUNAPRAYOON, Dan et al.Drugs & aging. 2006, Vol 23, Num 3, pp 251-262, issn 1170-229X, 12 p.Article